PTC Therapeutics, Inc. (PTCT) Financials

PTCT Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 1.8 billion 2.7 billion
2023-12-31 1.9 billion 2.7 billion
2023-09-30 1.3 billion 1.9 billion
2023-06-30 1.3 billion 1.9 billion

PTCT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 6.4 million 18.4 million
2023-12-31 -128.8 million 16.5 million
2023-09-30 -43.7 million 56.5 million
2023-06-30 -33.4 million 29.4 million

PTCT Net Income

No data available :(

PTCT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 - - 136.9 million
2023-12-31 876.7 million - 130.8 million
2023-09-30 294.8 million - 131.2 million
2023-06-30 337.9 million 572.6 million 130.0 million

PTCT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 76.7 million
2023-12-31 75.5 million
2023-09-30 75.4 million
2023-06-30 74.7 million

PTCT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 64.4 million 116.1 million 73.3 million -
2023-12-31 28.5 million 121.4 million 80.9 million -4.6 million
2023-09-30 29.2 million 164.2 million 80.9 million -
2023-06-30 19.3 million 185.9 million 40.5 million -

PTCT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 210.1 million 14.7 million
2023-12-31 307.1 million 106.3 million
2023-09-30 196.6 million 9.5 million
2023-06-30 213.8 million 12.7 million

PTCT

Price: $32.96

52 week price:
17.53
59.84

Earnings Per Share: -8.37 USD

P/E Ratio: -2.79

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 588300

Ebitda: -20.6 million

Market Capitalization: 2.6 billion

Links: